MedTrace Logo

Adipose Tissue and Serum Inflammation in GH Deficiency

NCT03500913 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2025-05-13

No results posted yet for this study

Summary

This study will examine adipose tissue inflammation and adipokine expression and serum markers of inflammation and adipokine levels in patients with growth hormone (GH) deficiency before and after treatment.

Conditions

  • Growth Hormone Deficiency

Interventions

DRUG

Growth Hormone

Patients will receive growth hormone replacement therapy as per standard clinical care during this study.

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Columbia University

    lead OTHER

Principal Investigators

  • Pamela U. Freda, MD · Columbia University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-19
Primary Completion
2020-02-12
Completion
2020-02-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03500913 on ClinicalTrials.gov